Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Edap Tms Sa ADR
(NQ:
EDAP
)
3.240
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Edap Tms Sa ADR
< Previous
1
2
Next >
EDAP Announces Reimbursement Approval in Switzerland for the Use of High-Intensity Focused Ultrasound (HIFU) in the Treatment of Prostate Cancer
July 26, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP to Present at the Jefferies Healthcare Conference
May 24, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces First Quarter 2023 Financial Results
May 17, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP to Announce First Quarter 2023 Financial Results on May 17, 2023
May 03, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces Major Presence at Upcoming Annual Meeting of the American Urological Association (AUA)
April 21, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience
April 10, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces Regulatory Clearance of ExactVu Micro-Ultrasound in Japan
April 06, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Reports Record Fourth Quarter and Full-Year 2022 Results and Announces Leadership Succession Plan to Develop Global Group Strategy
March 30, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Presents Positive Results from Non-Inferiority Study Comparing Outcomes of Focal One HIFU Versus Radical Prostatectomy at EAU23
March 21, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP to Announce Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 30th
March 09, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2022 Revenue
February 14, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces Positive Results from Phase 2 Study Evaluating Therapeutic High-Intensity Focused Ultrasound (HIFU) for the Treatment of Rectal Endometriosis
January 31, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces Record Q4 US Focal One Placements
January 05, 2023
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Appoints Medical Capital Equipment Finance Veteran Ken Mobeck as Chief Financial Officer of Company’s U.S. Subsidiary
December 06, 2022
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces Approval to Initiate Randomized Clinical Trial Evaluating Focal One® as a Potential Treatment for Rectal Deep Infiltrating Endometriosis
November 30, 2022
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP to Present at the Piper Sandler 34th Annual Healthcare Conference
November 21, 2022
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Reports Third Quarter 2022 Results
November 16, 2022
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP TMS SA to Announce Third Quarter 2022 Financial Results on Wednesday, November 16th, 2022
November 02, 2022
From
EDAP TMS S.A.
Via
GlobeNewswire
EDAP Announces Focal One® HIFU Reimbursement Raised to Urology APC Level 6 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY23
November 01, 2022
From
EDAP TMS S.A.
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.